ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. 

ViewPoint was founded in July of 2014 based on technology developed in the lab of Jason Gestwicki at the University of Michigan, in collaboration with the lab of Usha Andley at Washington University in St. Louis. 

Our operations are based in Janssen Labs at QB3@953 in San Francisco, California.